Bag it up: new device aims to make fibroid surgery safer
NCT ID NCT03281460
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether using a special bag during laparoscopic fibroid removal (myomectomy or hysterectomy) can prevent the spread of cells that might be cancerous. Forty-eight women were randomly assigned to have the procedure with or without the bag. Researchers then checked the fluid in the abdomen for any stray muscle cells. The goal is to make minimally invasive fibroid surgery safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
More-cell-Safe AMI bag (device) for morcellation
What this could lead to
If it works, this could make laparoscopic fibroid surgery safer by reducing the risk of spreading potentially harmful cells.
What could go wrong
This is a small, early-stage trial with only 48 participants, so results may not apply to all patients. The bag may not prevent all cell spread and could add surgical time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LAPAROSCOPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gynaecology Department, Hôpital Femme Mère Enfant
Bron, 69500, France